ADA and amyotrophic lateral sclerosis: In C9orf72 and some sporadic patients with ALS, adenosine deaminase is decreased in astrocytes, which leads to adenosine metabolism dysfunction, reduces bioenergetic output and causes toxicity in ALS astrocytes.